Peripheral Vascular Diseases  >>  emiplacel (PLX-PAD)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emiplacel (PLX-PAD) / Pluri, Charite - University of Medicine Berlin
NCT01679990: Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Completed
2
180
US, Europe, RoW
PLX-PAD Low dose, PLX-PAD high doses, Double Placebo, high dose +Placebo
Pluristem Ltd.
Intermittent Claudication, Peripheral Artery Disease
03/18
02/19

Download Options